Physician profile
Robert B Taylor
NPI 1992021083
$3,071.77
in general payments reported to CMS, 2019-2025
46 companies · $876 in 2025
The $876 reported for 2025 was less than what a typical Hematology (Internal Medicine) provider received nationally (typical 2025 total: $1,177).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $114 · 2020: $58.52 · 2021: $30.13 · 2022: $800 · 2023: $182 · 2024: $1,011 · 2025: $876.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,069.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,069.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Siemens Medical Solutions USA, INC. | $613.15 | 2022-2023 | Somatom Go.Top |
| Daiichi Sankyo INC. | $173.31 | 2024-2025 | Enhertu, Injectafer, Vanflyta |
| Novartis Pharmaceuticals Corporation | $152.54 | 2023-2025 | |
| Pfizer INC. | $135.03 | 2023-2025 | |
| Boston Scientific Corporation | $125.61 | 2022-2024 | Spaceoar Vue System - 10ml |
| Merck Sharp & Dohme LLC | $118.57 | 2023-2025 | Keytruda, Keytruda Qlex |
| Intuitive Surgical, INC. | $116.87 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $116.08 | 2024-2025 | Lynparza |
| Jazz Pharmaceuticals INC. | $100.50 | 2023-2025 | Zepzelca |
| Bayer Healthcare Pharmaceuticals INC. | $100.42 | 2024-2025 | |
| Astellas Pharma US INC | $98.46 | 2020-2025 | Padcev, Vyloy |
| Eisai INC. | $77.66 | 2019-2025 | |
| Janssen Biotech, INC. | $76.37 | 2022-2025 | Rybrevant |
| Teleflex LLC | $76.07 | 2024 | Urolift |
| Sobi, INC | $62.91 | 2024-2025 |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Taylor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.